Adlai Nortye Ltd. ADR ANL
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Adlai Nortye Ltd. ADR is the American Depositary Receipt representing shares of Adlai Nortye Ltd., a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cancer therapies. The company leverages its dual R&D presence in the United States and China to advance a robust pipelin…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees109
TickerANL
Statistics
Market Cap$1.80B
Revenue (TTM)$14.0M
Net Income—
Net Margin—
EPS—
P/E-9.41
P/S128.92
P/B—
EV/EBITDA-12.49
ROE-414.0%
Dividend Yield—
Price$10.22
Data: Twelve Data · Revenue = mcap / P/S